MedPath

A Study to find markers in blood and cerebrospinal fluid to help diagnose tuberculosis of the brai

Not Applicable
Conditions
Health Condition 1: A179- Tuberculosis of nervous system, unspecified
Registration Number
CTRI/2020/04/024423
Lead Sponsor
niversity Hospital Frankfurt
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Clinically suspected Central Nervous System Tuberculosis

Exclusion Criteria

•Informed consent not given

•Lumbar puncture not possible/not performed before start of treatment

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
â?¢Diagnostic accuracy (sensitivity, specificity, positive predictive value, negative predictive value) of biomarkers for differentiating CNS Tb and clinically relevant differential diagnosis (sarcoidosis, lymphoma, other infectious cause) <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: Baseline ( Date of Patient Enrollment ) and follow-up at 6 months
Secondary Outcome Measures
NameTimeMethod
â?¢Diagnostic accuracy (sensitivity, specificity, positive predictive value, negative predictive value) of biomarkers at 6 month follow up for treatment success and clinical outcomeTimepoint: Baseline ( Date of Patient Enrollment ) and follow-up at 6 months
© Copyright 2025. All Rights Reserved by MedPath